The Effect of Bevacizumab (Avastin) on Pterygium

PHASE2CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

March 31, 2010

Study Completion Date

March 31, 2010

Conditions
Pterygium
Interventions
DRUG

local injection of bevacizumab

Upon enrollment into the study: - initial injection of bevacizumab, a 1 week post-injection visit,and monthly visits thereafter for a total of 6 months. At the 1-month and 3-month visit post-injection visit, an additional bevacizumab injection will be offered if pterygium regression has not occurred. All injections of bevacizumab will consist of injecting 0.1mL of a 2.5mg/0.1mL concentration of bevacizumab into the head of the pterygium.

Trial Locations (1)

35233

Callahan Eye Foundation Hospital, Birmingham

All Listed Sponsors
lead

University of Alabama at Birmingham

OTHER

NCT00592176 - The Effect of Bevacizumab (Avastin) on Pterygium | Biotech Hunter | Biotech Hunter